These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8474136)

  • 21. Exploring the links between breast cancer and oestrogen.
    Wall A
    Community Nurse; 1998 Oct; 4(9):27-8. PubMed ID: 10326369
    [No Abstract]   [Full Text] [Related]  

  • 22. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
    DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
    J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms underlying social inequality in post-menopausal breast cancer.
    Hvidtfeldt UA
    Dan Med J; 2014 Oct; 61(10):B4922. PubMed ID: 25283627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lifetime menstrual activity--indicator of breast cancer risk.
    Rautalahti M; Albanes D; Virtamo J; Palmgren J; Haukka J; Heinonen OP
    Eur J Epidemiol; 1993 Jan; 9(1):17-25. PubMed ID: 8472797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Beral V; Reeves G; Bull D; Green J;
    J Natl Cancer Inst; 2011 Feb; 103(4):296-305. PubMed ID: 21278356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer risk factors. The latest facts, your best means of defense.
    Mayo Clin Womens Healthsource; 2007 Oct; 11(10):1-2. PubMed ID: 18418906
    [No Abstract]   [Full Text] [Related]  

  • 27. Hormone therapy and breast cancer risk 10 years after the WHI.
    Gompel A; Santen RJ
    Climacteric; 2012 Jun; 15(3):241-9. PubMed ID: 22612610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2011 Feb; 103(4):284-5. PubMed ID: 21278357
    [No Abstract]   [Full Text] [Related]  

  • 29. Breast cancer prevention in African-American women.
    Ursin G; Henderson BE
    J Natl Cancer Inst; 1996 Oct; 88(19):1332-3. PubMed ID: 8827006
    [No Abstract]   [Full Text] [Related]  

  • 30. Alcohol use, with hormone therapy, may increase breast cancer risk.
    Mayo Clin Womens Healthsource; 2006 May; 10(5):3. PubMed ID: 16585921
    [No Abstract]   [Full Text] [Related]  

  • 31. Racial differences in breast cancer trends in the United States (2000-2004).
    Pfeiffer RM; Mitani A; Matsuno RK; Anderson WF
    J Natl Cancer Inst; 2008 May; 100(10):751-2. PubMed ID: 18477805
    [No Abstract]   [Full Text] [Related]  

  • 32. Does estrogen replacement therapy reduce the risk of fatal breast cancer in postmenopausal women?
    Willis DB
    Maturitas; 1997 Jun; 27(2):105-8. PubMed ID: 9255744
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumor biology and prognosis in black breast cancer patients: a review.
    Rose DP; Royak-Schaler R
    Cancer Detect Prev; 2001; 25(1):16-31. PubMed ID: 11270418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
    Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
    J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer risk: effects of estrogen replacement therapy and body mass.
    Harris RE; Namboodiri KK; Wynder EL
    J Natl Cancer Inst; 1992 Oct; 84(20):1575-82. PubMed ID: 1404451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium.
    Palmer JR; Viscidi E; Troester MA; Hong CC; Schedin P; Bethea TN; Bandera EV; Borges V; McKinnon C; Haiman CA; Lunetta K; Kolonel LN; Rosenberg L; Olshan AF; Ambrosone CB
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25224496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmenopausal Female Hormone Use and Estrogen Receptor-Positive and -Negative Breast Cancer in African American Women.
    Rosenberg L; Bethea TN; Viscidi E; Hong CC; Troester MA; Bandera EV; Haiman CA; Kolonel LN; Olshan AF; Ambrosone CB; Palmer JR
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26613937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast-cancer etiology. Report of a working party for the Nordic Cancer Union.
    Adami HO; Adams G; Boyle P; Ewertz M; Lee NC; Lund E; Miller AB; Olsson H; Steel M; Trichopoulos D
    Int J Cancer Suppl; 1990; 5():22-39. PubMed ID: 2258263
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of anthropometric and nutritional factors on breast cancer risk in African-American women.
    Chandran U; Hirshfield KM; Bandera EV
    Public Health Nutr; 2012 Apr; 15(4):738-48. PubMed ID: 22122844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer.
    Tamimi RM; Spiegelman D; Smith-Warner SA; Wang M; Pazaris M; Willett WC; Eliassen AH; Hunter DJ
    Am J Epidemiol; 2016 Dec; 184(12):884-893. PubMed ID: 27923781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.